The semester-long course "Understanding New Health Technology Development" successfully concluded on December 9 with final presentations by students. The event provided an opportunity for participants to demonstrate their comprehensive understanding of the drug development process and gain practical experience with its complexities.

During the presentations, students analyzed and presented the development journey of globally recognized drugs, including Leqembi, Wegovy, and Zolgensma. Each team focused on the New Drug Application (NDA) process, addressing preclinical and clinical phases, regulatory hurdles, and market entry strategies. Their presentations showcased a well-rounded understanding of the scientific, regulatory, and market challenges involved in drug development.

The course was designed to emphasize the importance of interdisciplinary collaboration in creating new health technologies. Students explored critical decision-making principles at each stage of the development process, equipping themselves with practical knowledge essential for careers in the health tech sector. Key topics in the presentations included — The mechanism of action and scientific foundations of the drugs, Preclinical and clinical testing phases, Regulatory approval procedures, and Market strategies and societal impact.

One student shared, "This course gave us the unique opportunity to design and analyze the entire drug development process, offering invaluable insights that extend beyond theoretical knowledge." The "Understanding New Health Technology Development" course concluded successfully, marking a significant milestone in fostering future professionals equipped to advance the health technology field.